Cargando…
Advanced Imaging in Multiple Myeloma: New Frontiers for MRI
Plasma cell dyscrasias are estimated to newly affect almost 40,000 people in 2022. They fall on a spectrum of diseases ranging from relatively benign to malignant, the malignant end of the spectrum being multiple myeloma (MM). The International Myeloma Working Group (IMWG) has traditionally outlined...
Autores principales: | Torkian, Pooya, Azadbakht, Javid, Andrea Bonaffini, Pietro, Amini, Behrang, Chalian, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497462/ https://www.ncbi.nlm.nih.gov/pubmed/36140583 http://dx.doi.org/10.3390/diagnostics12092182 |
Ejemplares similares
-
Emerging Targets for the Treatment of Osteoarthritis: New Investigational Methods to Identify Neo-Vessels as Possible Targets for Embolization
por: Talaie, Reza, et al.
Publicado: (2022) -
Current Status and Future of Artificial Intelligence in MM Imaging: A Systematic Review
por: Alipour, Ehsan, et al.
Publicado: (2023) -
New Frontiers in the Treatment of Multiple Myeloma
por: Hwang, Janice Jin, et al.
Publicado: (2006) -
Osteoarthritis-Related Knee Pain Treated With Genicular Artery
Embolization: A Systematic Review and Meta-analysis
por: Torkian, Pooya, et al.
Publicado: (2021) -
Diagnostic Value of Whole-Body MRI Short Protocols in Bone Lesion Detection in Multiple Myeloma Patients
por: Ippolito, Davide, et al.
Publicado: (2021)